Sugen takes second shot at UK flotation
Thursday 15 May 1997
The California-based Sugen, which already has a quote on the US's Nasdaq exchange, deferred plans to float last year following a slump in UK biotechnology prices. However, recently revived confidence in the sector could herald a stream of biotech flotations over the next two years.
One flotation in the pipeline is Biovector Therapeutics, the French drug delivery company. It said yesterday it hoped to raise around $50m in a flotation in the UK or on Europe's Easdaq market early next year, a move that would value the group at around $150m. Biovector, which this month announced a tie-up with US group Biochem Pharma to develop an influenza vaccine, has appointed Dresdner Kleinwort Benson as advisers.
Sugen, which specialises in developing cancer drugs, does not plan to raise new money when it launches in the UK. Speaking at a biotechnology conference hosted by Rothschild in London yesterday, Stephen Evans-Freke, Sugen's founder and chief executive, said: "Our share price in the US does not make fund-raising sensible at this point.
"We want to reach a broader audience of European investors. We know many who are keen to take a position, but they are restricted at the moment."
Mr Evans-Freke said Sugen now had a lower risk profile after successfully taking its most advanced drug for brain cancer into late-stage clinical trials. "The time is right for us in the UK," he said.
British-born Mr Evans-Freke, who owns 5 per cent of the company, moved to the US where he sold his first biotechnology start-up, Selectide, to the Marion Merrill Dow drug giant, now part of Hoechst, for $58m in 1994. He founded Sugen in 1990, floating it on Nasdaq four years later.
After Zeneca, which invested $33m for its 20 per cent share, Sugen's second-largest shareholder is Rothschild's venture capital arm, Biotechnology Investments, which owns 6 per cent. Jeremy Curnock Cook, a director of Biotechnology Investments, took a seat on Sugen's board in January.
- 2 Mystery man who gave mum heart-warming note on train 'wanted to put a smile on her face'
- 5 Amal Clooney gives excellent answer to fashion question at European Court of Human Rights
King Salman: Just five days in, Saudi Arabia's new king has already overseen a beheading
Mystery man who gave mum heart-warming note on train 'wanted to put a smile on her face'
Michelle Obama highlights harsh restrictions faced by Saudi women after meeting King Salman without wearing a headscarf
Amal Clooney gives excellent answer to fashion question at European Court of Human Rights
Mafia's wall of silence broken: Victim of Cosa Nostra's extortion rackets in its Corleone heartland co-operates with authorities for the first time ever
'We would evict Queen from Buckingham Palace and allocate her council house,' say Greens
Greece elections: Syriza and EU on collision course after election win for left-wing party
British Muslim school children suffering a backlash of abuse following Paris attacks
British grandmother Lindsay Sandiford faces execution by firing squad in Indonesia
Liberal Democrat minister defends comments suggesting immigration causes pub closures
Louise Mensch says 'F**K YOU' in explosive tweets about David Cameron, Saudi Embassy and the Queen over King Abdullah tributes
iJobs Money & Business
£23000 - £26000 per annum + Benefits: Ashdown Group: Market Research Executive...
£25000 - £35000 per annum: Recruitment Genius: A Technical Report Writer is re...
Competitive salary & benefits!: MBDA UK Ltd: MBDA UK LTD Indirect Procurement...
£16500 - £16640 per annum: Recruitment Genius: This fast growing Finance compa...